Literature DB >> 2427092

Characterization and functional studies of rheumatoid synovial mast cells. Activation by secretagogues, anti-IgE, and a histamine-releasing lymphokine.

B Gruber, M Poznansky, E Boss, J Partin, P Gorevic, A P Kaplan.   

Abstract

Microscopic analysis of synovial specimens from 35 patients with rheumatoid arthritis (RA) and 7 patients with osteoarthritis revealed mast cell hyperplasia in perivascular regions, in fibrous interstitial areas, and clustered around the periphery of lymphoid aggregates. Metachromatic staining, immunofluorescence studies, and ultrastructural analysis revealed a single population of connective tissue-type mast cells with surface IgE receptors. Total extractable histamine of synovial tissue was 4.15 +/- 2.30 micrograms/gm (n = 8) for RA synovium and 0.53 +/- 0.23 microgram/gm (n = 7) for OA synovium. Mast cell secretion was assessed and specific release of histamine from RA synovial mast cells was observed following stimulation with anti-IgE (32.3%), compound 48/80 (40.1%), calcium ionophore A23187 (25.2%), and a partially purified lymphokine with histamine-releasing activity (23.9%).

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2427092     DOI: 10.1002/art.1780290802

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  22 in total

Review 1.  Mast cells. Receptors, secretagogues, and signaling.

Authors:  Bhavya B Sharma; John R Apgar; Fu-Tong Liu
Journal:  Clin Rev Allergy Immunol       Date:  2002-04       Impact factor: 8.667

2.  High IgE in rheumatoid arthritis (RA) patients is complexed with anti-IgE autoantibodies.

Authors:  N Millauer; A W Zuercher; S M Miescher; H A Gerber; M Seitz; B M Stadler
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

3.  Release of elastase from purified human lung mast cells and basophils. Identification as a Hageman factor cleaving enzyme.

Authors:  H L Meier; E S Schulman; L W Heck; D MacGlashan; H H Newball; A P Kaplan
Journal:  Inflammation       Date:  1989-06       Impact factor: 4.092

4.  IgE-containing immune complexes in synovial fluid of patients with rheumatoid arthritis.

Authors:  L S De Clerck; N J Struyf; C H Bridts; F C Breedveld; M L Westedt; A Cats; W J Stevens
Journal:  Clin Rheumatol       Date:  1990-06       Impact factor: 2.980

Review 5.  Mast cells in the rheumatoid lesion--ringleaders or innocent bystanders?

Authors:  D E Wooley
Journal:  Ann Rheum Dis       Date:  1995-07       Impact factor: 19.103

6.  Mast cells in the labial salivary glands of patients with Sjögren's syndrome: a histochemical, immunohistochemical, and electron microscopical study.

Authors:  Y T Konttinen; S Tuominen; M Segerberg-Konttinen; P Jungell; M J Malmström; M Grönblad; O Guven; S Santavirta; P Panula
Journal:  Ann Rheum Dis       Date:  1990-09       Impact factor: 19.103

7.  Measurement of the chemotactic complement fragment C5a in rheumatoid synovial fluids by radioimmunoassay: role of C5a in the acute inflammatory phase.

Authors:  P J Jose; I K Moss; R N Maini; T J Williams
Journal:  Ann Rheum Dis       Date:  1990-10       Impact factor: 19.103

8.  Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation.

Authors:  B L Gruber; M J Marchese; K Suzuki; L B Schwartz; Y Okada; H Nagase; N S Ramamurthy
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

9.  Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma.

Authors:  Z Qu; J M Liebler; M R Powers; T Galey; P Ahmadi; X N Huang; J C Ansel; J H Butterfield; S R Planck; J T Rosenbaum
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

10.  Mast cell activation in human synovium explants by calcium ionophore A23187, compound 48/80, and rabbit IgG anti-human IgE, but not morphine sulfate.

Authors:  J W Verbsky; P K McAllister; D G Malone
Journal:  Inflamm Res       Date:  1996-01       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.